Ragosa Mark bought KNSA
March 9, 2026 · Form 4 insider transaction
Ragosa Mark bought 2,036 shares of Kiniksa Pharmaceuticals International, plc at $22.89 per share, a transaction worth $46.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,036
Price
$22.89
Total value
$46.6K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateMarch 9, 2026
Filing dateMarch 11, 2026
Shares owned after14,122
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.